Docs at the AMA’s Interim Meeting in Orlando, Florida, have voted to support greater oversight of nonprofit hospitals and to standardize charity care policies.  

Pylarify is a PSMA-targeted PET agent for pinpointing suspected metastasis or recurrence of prostate cancer, which will be impacted by a new Medicare policy change.  

HATco, part of General Catalyst, is set to purchase the Ohio-based health system, which currently has roughly $850 million in debt on its balance sheet. 

Six multispecialty cardiovascular societies have called on CMS to approve Medicare payments for tricuspid transcatheter edge-to-edge repair (T-TEER).

However, an analysis from research firm PitchBook suggests a rebound could be on the horizon, as investors shift their gaze to specialty care services. 

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

ACR is asking the imaging community to contact their federal representatives, urging them to pass three key pieces of legislation before Jan. 1. 

The VA is throwing in with the FDA to launch a cross-agency AI testing facility.